27 results
8-K
EX-2.1
KNTE
Kinnate Biopharma Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:10am
senior leadership team, which agreements provide for the payment of a transaction bonus in the event that the Transactions are consummated, subject
8-K
KNTE
Kinnate Biopharma Inc
22 Nov 23
Departure of Directors or Certain Officers
4:05pm
”) and two other members of its senior leadership team, which provide for the payment of a transaction bonus in the event of a transaction involving … executive officer, and 15% for each of the other two members of the senior leadership team, subject to potential adjustment for each executive eligible
8-K
EX-99.1
ddycit wckqn
16 Aug 21
Kinnate Biopharma Inc. Reports Second Quarter 2021 Financial Results
4:27pm
8-K
EX-99.1
x2ybawbouwqbc0s85oy
28 Jun 21
Kinnate Biopharma Inc. Appoints Helen Sabzevari, Ph.D. to Board of Directors
8:06am
8-K
EX-99.1
ea23 5xt39amsg10zs
7 Jun 21
Experienced leaders bring substantial clinical research, regulatory, and operational expertise in the biopharmaceutical industry to the Kinnate team
8:07am
10-Q
3x5vu pxxcsda2m16n04
17 May 21
Quarterly report
4:26pm
DEF 14A
9e9e4y8v6t oe
30 Apr 21
Definitive proxy
9:13am
10-K
e4082
29 Mar 21
Annual report
4:26pm
424B4
tld5ntiijjcao6qng
3 Dec 20
Prospectus supplement with pricing info
4:48pm